Longevity – Are we getting younger?

About this session

Longevity science is transitioning from research curiosity to serious commercial opportunity, with interventions aimed at slowing or reversing aging processes gaining scientific credibility and investor attention. This session explores the latest developments in aging biology and health span extension, examines what the emerging data reveals about therapeutic potential, and discusses the investment landscape taking shape around longevity.

Speakers

• PN

  Phil Newman

  Founder & CEO · Longevity Technology

  Moderator

• CC

  Clara Campas

  Managing Partner · Asabys

  Panelist

• PP

  Pedro de Noronha Pissarra

  CEO · Chrysea Limited

  Panelist

• CK

  Carina Kern

  CEO · LinkGevity

  Panelist

• NR

  Nikolaj Kulahin Roed

  Global Project Leader · Novo

  Panelist